POSB22 Indirect Treatment Comparisons of Empagliflozin Versus Sacubitril/Valsartan for the Treatment of Patients with Heart Failure with Reduced Ejection Fraction (HFREF)
| Autor: | Smith, S, Pilkington, H, Roskell, N, Linden, S, Bellanca, L |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S29-S29 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect